Clinical trial of Inofer: last patient out
All samples from patients included in the clinical study of the iron tablets Inofer have now been obtained. As earlier announced, a clinical trial of Inofer was approved by the Swedish Medical Products Agency and the National Ethical Committee June 20, 2018, and the study started on October 4 when the first patient received treatment with Inofer tablets. The study was conducted at Skellefteå Hospital and was led by the chief physician Kurt Boman, senior professor at Umeå University. Drugsson AB, which is the subsidiary of Double Bond Pharmaceutical (DBP), has the rights to distribute Inofer